Smith Patrick W
- SEC CIK
- 0001167028
In the past year, 12 open-market sale filings worth $67.4M and no purchases.
Current role at each company
- AXON Axon Enterprise, Inc.CHIEF EXECUTIVE OFFICERas of Sep 10, 2026
- IMDX Insight Molecular Diagnostics Inc.10% Owneras of Feb 11, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $67.4M
- 12 filings
- Net
- −$67.4M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Smith Patrick W as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AXON Axon Enterprise, Inc.
CHIEF EXECUTIVE OFFICER37 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 6, 2021 (view filing) | Aug 6 | Same day | Smith Patrick WCHIEF EXECUTIVE OFFICER | SSale | −31.3K | $198.00 | −$6.20M | −7.1%407.5K after | |
| Oct 18, 2021 (view filing) | Oct 14-18 | 4 days | Smith Patrick WCHIEF EXECUTIVE OFFICER | SSale | −34.8K | $181.26 | −$6.30M | −7.1%452.7K after | 8 lots |
| Oct 21, 2021 (view filing) | Oct 19-21 | 2 days | Smith Patrick WCHIEF EXECUTIVE OFFICER | SSale | −138.7K | $183.07 | −$25.4M | −20.4%540.8K after | 21 lots |
| Oct 26, 2021 (view filing) | Oct 22-26 | 4 days | Smith Patrick WCHIEF EXECUTIVE OFFICER | SSale | −129.0K | $181.51 | −$23.4M | −17.1%623.2K after | 18 lots |
| Nov 2, 2021 (view filing) | Oct 29-Nov 2 | 4 days | Smith Patrick WCHIEF EXECUTIVE OFFICER | SSale | −95.2K | $180.80 | −$17.2M | −12.2%683.6K after | 9 lots |
| Nov 5, 2021 (view filing) | Nov 3-5 | 2 days | Smith Patrick WCHIEF EXECUTIVE OFFICER | SSale | −141.8K | $183.57 | −$26.0M | −15.5%774.0K after | 15 lots |
| Nov 10, 2021 (view filing) | Nov 8-9 | 2 days | Smith Patrick WCHIEF EXECUTIVE OFFICER | SSale | −2.22K | $180.59 | −$400.2K | −0.3%775.5K after | 6 lots |
| Nov 17, 2021 (view filing) | Nov 16 | 1 day | Smith Patrick WCHIEF EXECUTIVE OFFICER | SSale | −330.0K | $186.25 | −$61.5M | −13.8%2.07M after | 26 lots |
| Nov 19, 2021 (view filing) | Nov 17-19 | 2 days | Smith Patrick WCHIEF EXECUTIVE OFFICER | SSale | −137.3K | $181.61 | −$24.9M | −6.0%2.15M after | 9 lots |
| Nov 29, 2021 (view filing) | Nov 24-29 | 5 days | Smith Patrick WCHIEF EXECUTIVE OFFICER | SSale | −78.5K | $180.10 | −$14.1M | −3.4%2.20M after | 6 lots |
IMDX Insight Molecular Diagnostics Inc.
10% Owner5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 27, 2024 (view filing) | Dec 26 | 1 day | Smith Patrick W10% Owner | PPurchaseCommon Stock, no par value | +90.2K | $2.13 | +$192.2K | +5.4%1.77M after | |
| Jan 15, 2025 (view filing) | Jan 13-14 | 2 days | Smith Patrick W10% Owner | PPurchaseCommon Stock, no par value | +16.1K | $2.12 | +$34.1K | +0.9%1.79M after | 3 lots |
| Jan 31, 2025 (view filing) | Jan 29-30 | 2 days | Smith Patrick W10% Owner | PPurchaseCommon Stock, no par value | +4.20K | $2.01 | +$8.44K | +0.2%1.79M after | 2 lots |
| Feb 4, 2025 (view filing) | Jan 31-Feb 4 | 4 days | Smith Patrick W10% Owner | PPurchaseCommon Stock, no par value | +915 | $2.01 | +$1.84K | +0.1%1.80M after | 2 lots |
| Feb 11, 2025 (view filing) | Feb 7 | 4 days | Smith Patrick W10% Owner | PPurchaseCommon Stock, no par value | +1.08M | $2.05 | +$2.21M | +60.0%2.87M after |